4//SEC Filing
Flynn Patrick John 4
Accession 0001415889-22-011810
CIK 0001719406other
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 7:00 AM ET
Size
11.3 KB
Accession
0001415889-22-011810
Insider Transaction Report
Form 4
Flynn Patrick John
Director
Transactions
- Purchase
Common Stock, par value $0.001 per share
2022-11-28$1.25/sh+2,500$3,125→ 37,709 total(indirect: By Trust) - Purchase
Common Stock, par value $0.001 per share
2022-11-28$1.25/sh+2,500$3,125→ 37,709 total(indirect: By Trust) - Purchase
Common Stock, par value $0.001 per share
2022-11-28$1.25/sh+2,500$3,125→ 40,209 total(indirect: By Trust) - Purchase
Common Stock, par value $0.001 per share
2022-11-28$1.24/sh+2,500$3,100→ 40,209 total(indirect: By Trust) - Purchase
Common Stock, par value $0.001 per share
2022-11-28$1.25/sh+1,750$2,188→ 1,750 total
Footnotes (4)
- [F1]Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
- [F2]Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
- [F3]Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
- [F4]Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
Related Parties
1- filerCIK 0001864871
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 7:00 AM ET
- Size
- 11.3 KB